Armata Pharmaceuticals Inc
Veridion Score
Composite trend over time
Why is ARMP moving today?
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for ARMP.
ARMP insider activity
Armata Pharmaceuticals Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$94K across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-03-14 | Kyme Pierre | Insider | sell | $10.54 | 1,030 | 9,461 | $11K | SEC Form 4 |
| 2026-03-17 | 2026-03-14 | Birx Deborah | Insider | sell | $10.54 | 4,919 | 212,458 | $52K | SEC Form 4 |
| 2025-07-14 | 2025-07-10 | Birx Deborah | Insider | sell | $2.27 | 13,637 | 217,377 | $31K | SEC Form 4 |
ARMP contract awards, year to date.
Public federal awards linked to this ticker.
ARMP lobbying filings, year to date.
Registered lobbying filings matched to Armata Pharmaceuticals Inc.